Real-World Experience with Lenvatinib plus Pembrolizumab in Metastatic <i>BRAF</i> Wild-Type Anaplastic Thyroid Carcinoma
Our real-world experience with L/P in metastatic <i>BRAF<sup>WT</sup></i>-ATC demonstrates the clinical efficacy and safety of this combination, consistent with prior reports. A prospective clinical trial in the United States is ongoing (NCT#04171622).
Authors
- Danica M. Vodopivec (ORCID: https://orcid.org/0000-0001-6605-4667)
- Sarah Hamidi (ORCID: https://orcid.org/0000-0002-1528-9885)
- Priyanka Chandrasekhar Iyer (ORCID: https://orcid.org/0000-0003-4863-5585)
- Mark Zafereo (ORCID: https://orcid.org/0000-0001-7918-9739)
- Anna F. Lee (ORCID: https://orcid.org/0000-0002-6703-0656)
- Neal S. Akhave (ORCID: https://orcid.org/0000-0002-1291-0218)
- Vicente Rodrigues Marczyk (ORCID: https://orcid.org/0000-0001-7005-722X)
- Matthew S. Ning (ORCID: https://orcid.org/0000-0002-2932-5584)
- Maria Gule-Monroe (ORCID: https://orcid.org/0000-0002-4418-3705)
- Isabelle Fournier (ORCID: https://orcid.org/0000-0003-1096-5044)
- Steven Gerard Waguespack (ORCID: https://orcid.org/0000-0003-0280-0100)
- Renata Ferraroto
- Naifa Lamki Busaidy (ORCID: https://orcid.org/0000-0002-3808-6378)
- Anastasios Maniakas (ORCID: https://orcid.org/0000-0002-4354-2841)
- Ramona Dadu (ORCID: https://orcid.org/0000-0002-3776-208X)
- Maria E. Cabanillas (ORCID: https://orcid.org/0000-0002-5124-1811)
- Jennifer Wang (ORCID: https://orcid.org/0000-0002-7897-007X)
- Luana G. Sousa
- Victoria E. Banuchi
- G. Brandon Gunn
- Micheal T. Spiotto
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- University of Alabama at Birmingham (US)
Publication Details
- Journal
- Thyroid
- Published
- 2026-01-07
- DOI
- https://doi.org/10.1177/10507256251409138
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00